--- title: "Hong Kong stock movement: Clinical progress in innovative drugs boosts INSILICO's stock price by nearly 16%" type: "News" locale: "en" url: "https://longbridge.com/en/news/272207716.md" description: "INSILICO rose 15.96%; YIDU TECH rose 7.78%, with a transaction volume of HKD 143 million; BRAINAURORA-B rose 2.17%, with a transaction volume of HKD 134 million; Yimaitong rose 2.19%, with a transaction volume of HKD 129 million; iFlytek Medical Technology rose 4.87%, with a market value of HKD 12.4 billion" datetime: "2026-01-12T02:32:10.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/272207716.md) - [en](https://longbridge.com/en/news/272207716.md) - [zh-HK](https://longbridge.com/zh-HK/news/272207716.md) --- # Hong Kong stock movement: Clinical progress in innovative drugs boosts INSILICO's stock price by nearly 16% **Hong Kong Stock Movement** INSILICO rose 15.96%. Based on recent key news: 1. On January 12, INSILICO announced that its innovative PHD inhibitor ISM5411 completed the first subject dosing in Phase IIa clinical trials. The drug, developed by the Pharma.AI platform, is intended for the treatment of inflammatory bowel disease and has received approval from the United States Adopted Names Council. This news drove the stock price up. 2. On January 12, INSILICO's ISM5411 demonstrated potential clinical application value in the BETHESDA clinical trial, with plans to evaluate its safety and efficacy in approximately 80 patients. This clinical progress enhanced market confidence, further driving the stock price up. 3. On January 12, INSILICO was highlighted in Nature Biotechnology as a leader in applying generative AI to address unmet needs in inflammatory bowel disease, strengthening its market positioning and commercial potential, which promoted the stock price increase. The AI pharmaceutical field is still in the exploratory stage. **Stocks with High Trading Volume in the Industry** YIDU TECH rose 7.78%, with a trading volume of HKD 143 million, and no significant news recently. The trading is active, with clear capital flow. Considering the sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. BRAINAURORA-B rose 2.17%. Based on recent key news: 1. On January 12, BRAINAURORA-B recorded large trades in pre-market trading, with a transaction price 8.55% lower than the previous close, indicating market caution regarding its short-term prospects. This transaction involved an amount of HKD 53.92 million, reflecting increased investor attention on the stock. 2. On January 8, BRAINAURORA-B shareholders deposited shares into HSBC Hong Kong, with a market value of HKD 742 million, accounting for 8.13%. This move may indicate shareholders' confidence in the company's future development, driving the stock price up. 3. BRAINAURORA-B's interim results as of June 30, 2025, showed a year-on-year revenue increase of 92.82%, but net losses increased, raising market concerns about its profitability, which may affect stock price volatility. The Hong Kong stock market has seen increased volatility recently, requiring attention. Yimaitong rose 2.19%, with a trading volume of HKD 129 million, and no significant news recently. The trading is active, with clear capital flow. Considering the sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. **Stocks with High Market Capitalization in the Industry** iFlytek Medical Technology rose 4.87%. Based on recent key news: 1. On January 11, the capital market revalued AI companies, and iFlytek Medical Technology secured a national-level pilot project, becoming a leader in medical AI acceptance. Source: Zhito Finance, with increased policy support for the AI medical field. 2. On January 9, MiniMax surged over 100% on its first day of listing, igniting interest in artificial intelligence applications and driving iFlytek Medical Technology's stock price up. iFlytek Medical Technology's gains expanded to 25% at the end of trading, closing up 20.58%, with a trading volume of HKD 190 million Source: Zhitong Finance On January 8, OpenAI launched the ChatGPT Health feature, further promoting the development of AI in the medical field. Northeast Securities pointed out that large model manufacturers are strengthening their layout in healthcare, and policy support continues to increase. Source: Zhitong Finance ### Related Stocks - [03696.HK](https://longbridge.com/en/quote/03696.HK.md) - [02158.HK](https://longbridge.com/en/quote/02158.HK.md) - [06681.HK](https://longbridge.com/en/quote/06681.HK.md) ## Related News & Research - [Yidu Tech Wins SGD 2.28 Million Dr Buddy Contract in Singapore Expansion Push](https://longbridge.com/en/news/285282293.md) - [Don't let these 3 AI investing mistakes destroy your gains](https://longbridge.com/en/news/284973764.md) - [Marc Andreessen's custom AI prompt calls for blunt, aggressive answers](https://longbridge.com/en/news/285236675.md) - [SPARC AI Hires Senergy Communication Capital | SPAIF Stock News](https://longbridge.com/en/news/285163916.md) - [Rocket Doctor AI Inc. GAAP EPS of $0.10, revenue of $1.73B](https://longbridge.com/en/news/285110335.md)